0001209191-20-013032.txt : 20200226
0001209191-20-013032.hdr.sgml : 20200226
20200226163525
ACCESSION NUMBER: 0001209191-20-013032
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200224
FILED AS OF DATE: 20200226
DATE AS OF CHANGE: 20200226
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Parini Michael
CENTRAL INDEX KEY: 0001661567
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 20656294
MAIL ADDRESS:
STREET 1: C/O VERTEX PHARMACEUTICALS, INC.
STREET 2: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-02-24
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001661567
Parini Michael
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
EVP, CL&AO
Common Stock
2020-02-24
4
F
0
2416
239.23
D
29866
D
Common Stock
2020-02-25
4
S
0
938
230.07
D
28928
D
Common Stock
2020-02-25
4
S
0
330
231.62
D
28598
D
Common Stock
2020-02-25
4
S
0
320
232.89
D
28278
D
Common Stock
2020-02-25
4
S
0
640
234.77
D
27638
D
Common Stock
2020-02-25
4
S
0
320
236.26
D
27318
D
Common Stock
2020-02-25
4
S
0
480
238.30
D
26838
D
Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $230.07 (range $229.75 to $230.57).
Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $231.62 (range $231.12 to $232.06).
Open market sales reported on this line occurred at a weighted average price of $232.89 (range $232.73 to $233.05).
Open market sales reported on this line occurred at a weighted average price of $234.77 (range $234.51 to $235.46).
Open market sales reported on this line occurred at a weighted average price of $236.26 (range $235.72 to $236.80).
Open market sales reported on this line occurred at a weighted average price of $238.30 (range $238.16 to $238.54).
/s/ Omar White, Attorney-in-Fact
2020-02-26